Haemophilus influenzae Clinical Isolates with Plasmid pB1000 Bearing bla ROB-1 : Fitness Cost and Interspecies Dissemination

Antimicrobial Agents and Chemotherapy
2010.0

Abstract

Plasmid pB1000 is a mobilizable replicon bearing the bla(ROB-1) beta-lactamase gene that we have recently described in Haemophilus parasuis and Pasteurella multocida animal isolates. Here we report the presence of pB1000 and a derivative plasmid, pB1000', in four Haemophilus influenzae clinical isolates of human origin. Pulsed-field gel electrophoresis showed unrelated patterns in all strains, indicating that the existence of pB1000 in H. influenzae isolates is not the consequence of clonal dissemination. The replicon can be transferred both by transformation and by conjugation into H. influenzae, giving rise to recipients resistant to ampicillin and cefaclor (MICs, > or =64 microg/ml). Stability experiments showed that pB1000 is stable in H. influenzae without antimicrobial pressure for at least 60 generations. Competition experiments between isogenic H. influenzae strains with and without pB1000 revealed a competitive disadvantage of 9% per 10 generations for the transformant versus the recipient. The complete nucleotide sequences of nine pB1000 plasmids from human and animal isolates, as well as the epidemiological data, suggest that animal isolates belonging to the Pasteurellaceae act as an antimicrobial resistance reservoir for H. influenzae. Further, since P. multocida is the only member of this family that can colonize both humans and animals, we propose that P. multocida is the vehicle for the transport of pB1000 between animal- and human-adapted members of the Pasteurellaceae.

Knowledge Graph

Similar Paper

Haemophilus influenzae Clinical Isolates with Plasmid pB1000 Bearing bla <sub>ROB-1</sub> : Fitness Cost and Interspecies Dissemination
Antimicrobial Agents and Chemotherapy 2010.0
β-Lactam Resistance in Haemophilus parasuis Is Mediated by Plasmid pB1000 Bearing bla <sub>ROB-1</sub>
Antimicrobial Agents and Chemotherapy 2007.0
Multiresistance in Pasteurella multocida Is Mediated by Coexistence of Small Plasmids
Antimicrobial Agents and Chemotherapy 2009.0
Genotypic versus Phenotypic Characterization, with Respect to β-Lactam Susceptibility, of Haemophilus influenzae Isolates Exhibiting Decreased Susceptibility to β-Lactam Resistance Markers
Antimicrobial Agents and Chemotherapy 2009.0
Horizontal Gene Transfer of ftsI , Encoding Penicillin-Binding Protein 3, in Haemophilus influenzae
Antimicrobial Agents and Chemotherapy 2007.0
Diversity of Ampicillin Resistance Genes and Antimicrobial Susceptibility Patterns in Haemophilus influenzae Strains Isolated in Korea
Antimicrobial Agents and Chemotherapy 2007.0
Antimicrobial Activities of Piperacillin-Tazobactam against Haemophilus influenzae Isolates, Including β-Lactamase-Negative Ampicillin-Resistant and β-Lactamase-Positive Amoxicillin- Clavulanate-Resistant Isolates, and Mutations in Their Quinolone Resistance-Determining Regions
Antimicrobial Agents and Chemotherapy 2009.0
Acquisition of a Plasmid-Borne bla <sub>OXA-58</sub> Gene with an Upstream IS 1008 Insertion Conferring a High Level of Carbapenem Resistance to Acinetobacter baumannii
Antimicrobial Agents and Chemotherapy 2008.0
High Diversity of Extended-Spectrum β-Lactamases in Escherichia coli Isolates from Italian Broiler Flocks
Antimicrobial Agents and Chemotherapy 2010.0
IncI1 Plasmid Carrying Extended-Spectrum-β-Lactamase Gene bla <sub>CTX-M-1</sub> in Salmonella enterica Isolates from Poultry and Humans in France, 2003 to 2008
Antimicrobial Agents and Chemotherapy 2010.0